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Analysis of the filed data of a sample of Egyptian children                    
with bronchial asthma  
 
INTRODUCTION 
Asthma is a highly prevalent chronic respiratory 
disease affecting 300 million people world-wide 1. 
The burden of this disease to governments, health 
care systems, families, and patients is increasing 
worldwide. 
The rate of asthma increases as communities 
adopt western lifestyles and become urbanized. 
With the projected increase in the proportion of the 
world's urban population from 45% to 59% in 2005, 
there will likely be a marked increase in the number 
of asthmatics worldwide over the next two decades. 
It is estimated that there may be an additional 100 
million persons with asthma by 2025 2. 
Asthma is by far the commonest of all chronic 
diseases of childhood and estimates from developed 
countries suggest that it affects between 11 and  
 
 
20% of all school age children3. The prevalence of 
asthma among Egyptian children aged 3 - 15 years 
was estimated to be 8.2%. Of major concern is the 
annual increase in mortalitity4. Asthma is a 
common cause of emergency room visits and 
hospital admissions. The burden of asthma is higher 
than generally recognized, particularly in children. 
For example, in Egypt up to one in four children 
with asthma is unable to attend school regularly 
because of poor asthma control5. 
It is estimated that asthma accounts for about 
one in every 250 deaths worldwide. Many of the 
deaths are preventable, being due to suboptimal 
long-term medical care and delay in obtaining help 
during acute exacerbation. Barriers to reducing the 
burden of asthma include generic barriers like 
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poverty, poor disease education, and poor health 
services infrastructure and environmental barriers 
like indoor and outdoor air pollution, tobacco 
smoking, and occupational exposure. Moreover 
symptom-based rather than disease-based 
approaches to the management of asthma and 
tendency of care to be "acute" rather than "regular" 
are significant barriers. Patient barriers include; 
lack of information, under-use of self management, 
over-reliance on acute care and cultural attitudes 
towards drugs and drug delivery systems like for 
example steroids and inhalers2 . 
The study aims at evaluation of the profile and 
management outcome of asthmatic children at the 
Pediatric Allergy and Immunology Unit of Ain 
Shams University, Children's Hospital. This is 
sought for through assessment of the demographic 
data of the patients, course and sequelae of illness, 
and efficacy of the various therapeutic strategies 
adopted. We were also trying to establish a proper 
database for the patients in the Pediatric Allergy 




This retrospective data analysis comprised revision 
of the files of 422 asthmatic children (286 males 
and 136 females), 197 children (46.7%) had 
bronchial asthma only and the other 225 children 
(53.3%) had bronchial asthma with other allergic 
diseases (atopic dermatitis, allergic rhinitis or food 
allergy). They presented to the Pediatric Allergy 
and Immunology Clinic, Children's Hospital, Ain 
Shams University in the period from February 1988 
to October 2005.  
The age at onset  defined as the age of the first 
physical symptom or sign consistent with the 
diagnosis of bronchial asthma ranged from the 
neonatal period to 8.6 years with a mean of 0.97 ± 
1.33 years, and the duration of follow up from 0.6 
to 13 with a mean of 4.31 ± 2.93 years.  
The status at last visit was categorized as:  
- Uncontrolled disease on enrollment: persistent 
symptoms despite compliance on treatment.  
- Controlled disease on enrollment: defined as 
complete absence of asthma symptoms in 
subjects not taking any asthma medication prior 








Study Methods:  
Medical records were retrospectively examined and 
the following data were collected (whenever 
available) in a computer data base till analysis was 
undertaken: 
 
I. Clinical and epidemiological data:  
- Personal and demographic data, e.g. sex and 
residence.  
- Age at onset, and duration of follow-up.  
- Precipitating factors for acute exacerbation 
including: environmental factors, foods, viral 
infections, endocrinal factors, psychological 
factors, irritants such as cold air and parental 
smoking and noxious fumes and drugs such as 
aspirin and sulfonamide.  
- Clinical findings during acute exacerbation 
including cough, dyspnea, cyanosis, low grade 
fever and profuse sweating.  
- Symptoms of other atopic diseases in the child 
such as atopic dermatitis, allergic rhinitis and 
food allergy.  
- History of absolute breast feeding or artificial 
feeding. 
- Asthma grading at diagnosis.  
- Outcome and course of the disease.  
II. Available laboratory data:  
a) Complete blood count on the first visit (Coulter 
Counter, Beckman Inc, Florida, USA).  
b) ESR by Westergren method on the first visit.  
c) Serum total IgE on the first visit by ELISA.  
III. Available imaging data:  
Plain X-ray of the chest on the first visit for 
infiltrations, hyperinflation or effusions.  
IV. Treatment data:  
Medication received: type, route of administration 
and compliance.  
 
Statistical analysis: 
First, simple frequency, mean, standard deviation 
and range were calculated. Thereafter, comparison 
between active and remission cases with bronchial 
asthma was done using the student's t-test for 
continuous variables and Pearson's Chi square test 
for categorical variables.  
All statistical analyses were performed using 
the statistical package for social science (SPSS) 
version 11.0 (SPSS Inc. Head quarters. Chicago, 







































































































Figure 1. The number of newly diagnosed 
cases/year during the period from 1988 to 2005     
  
More than half of the cases had an associated 








Bronchial asthma + allergic rhinitis
Bronchial asthma + atopic dermatitis
Bronchial asthma + food allergy  




Table 1. Factors precipitating exacerbations of 
bronchial asthma in this series. 
Precipitating  
factors 
Number of cases 
(N=422) 
Viral infections  
Cold air 


















As regards asthma grading, data were available 
in 403 files, of which mild intermittent bronchial 
asthma was the most common presentation [295 
cases, (73.2%)], followed by mild persistent, [61 
cases, (15.1%)], moderate persistent [41 cases, 
(10.2%)], and only [6 cases, (1.5%)] had severe 






MI MP MoP SP
 
MI: mild intermittent; MP: mild persistent; MoP: moderate 
persistent; SP: severe persistent. 
Figure 3.  Grading of bronchial asthma at diagnosis 
 
Demographic data analysis revealed that 
bronchial asthma was more common in males (286 
cases) than in females (136 cases) in a ratio of 
2.1:1. The number of cases coming from urban 
areas were higher than those coming from suburban 
and rural areas [288 (68.2%) versus 116 (27.5%) 
and 11 (2.6%) respectively]. The mean age at onset 
was 0.97 ± 1.33 years and the mean duration of 
follow-up was 4.3 ± 2.93 years.  
Family history of bronchial asthma was positive in 
134 cases (31.8%) of our studied patients and 38 
(9%) had family history of other atopic diseases in 
1st, 2nd, or 3rd degree relatives. 
Viral infections were the commonest 
precipitating factor of bronchial asthma 
exacerbation in our patients [163 cases (38.6%)]. 
This was followed by exposure to cold [155 cases 
(36.7%)]. Other precipitating factors are shown in 
Table 1.  
Dyspnea, cough and cyanosis were the most 
frequent symptoms of bronchial asthma 
exacerbation in our patients (Table 2). 
Regarding infant feeding, 182 infants (43.1%) 
were absolutely breast fed and 28 cases (6.6%) 
were artificially fed. 
At the onset of the disease, the Hb 
concentration at onset varied from marked anemia 
to normal Hb (mean ± SD = 10.9 ± 1.54 gm/dl), 
platelet counts ranged from 160x103 to 
973x103/cmm with a mean counts of 361.51 ± 
152.23x103/cmm, the total leucocytic count also 
varied considerably from 3.7x103 to 19.7x103/cmm, 
and the eosinophilic counts ranged from zero to 
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12% with a mean of 10.54 ± 15.65. The mean ESR 
at onset was 17.37 ± 12.68 mm/hr. Serum total IgE 
level was high for age in 133 cases (31.5%) and 
normal in 54 cases (12.79%) with no data available 
for the remaining patients. 
 
Table 2. Frequency of clinical symptoms during 
acute exacerbations of bronchial asthma in our 
patients. 
Bronchial asthma cases 





Low grade fever 
Vomiting  














Inhaled corticosteroids (Budesonide or 
Fluticasone) were used by all patients of persistent 
asthma, long acting theophylline was used by 56 of 
them (51.9%), long acting B2-agonist (salmeterol) 
by 5 cases (4.6%) and oral steroids by 5  (4.6%) 
(Table 3). 
 
Table 3. Overview of medications used by patients 
with persistent bronchial asthma. 



















Concerning the status of the patients followed 
up at the time of data analysis (144), 49 patients 
were showing manifestations of uncontrolled 
asthma and 95 cases had controlled disease. Gender 
difference, family history of atopy, age of onset, 
nature of precipitating factor, type of feeding, 
presence of other atopic disease, or any laboratory 
parameter    had no influence on the course of the 
disease whether controlled or not. 
The number of patients with uncontrolled 
disease was significantly higher in the moderate 
persistent grade compared to the mild intermittent, 




The development and phenotypic expression of 
allergic diseases depends on a complex interaction 
between genetic factors, environmental exposure to 
allergens, and non-specific adjuvant factors, such as 
tobacco smoke, air pollution and infections. 
Identification of these factors is the most crucial 
problem in the epidemiology of allergic diseases7, 
and preventive measures should be targeted to 
reduce exposure to allergens and to adjuvant risk 
factors. The objective for this study was to identify 
the possible associations of importance in disease 
course and outcome in our unit.  
In our study, we revised the files of 422 
children who were diagnosed as having bronchial 
asthma; alone or in association with other allergic 
diseases. The number of newly diagnosed cases per 
year as shown in figure (1), bronchial asthma was 
the most common, followed by atopic dermatitis 
and then allergic rhinitis. Different findings were 
reported by Kalyoncu et al8, who reported that the 
prevalence rates of asthma, wheezing, rhinitis and 
AD were 16.8%, 22.5%, 18.7%, 6.5% and 9.8%, 
13.3%, 14.1%, 4.3% in 358 boys and 380 girls from 
Turkey respectively.  
The risk of developing bronchial asthma was 
higher for boys than for girls, as shown from the 
current data.  This result comes in accordance with 
the data of Redline and Gold 9 and by Kalyoncu and 
coworkers8, who stated that male gender was a 
significant risk factor for asthma and wheezing. 
This observation may reflect a sex-linked influence 
or may be due to different environmental exposure 
patterns 7.  
We observed that allergic diseases were more 
prevalent in urban residents followed by suburban 
residents with few cases coming from rural areas. 
These differences can be partially explained by 
differences in environment exposures, such as air 
pollution, and exposure to allergens, such as 
pollens, cockroaches, and house dust mites. Several 
studies from Europe, Canada, and Australia have 
suggested that agricultural exposures may protect 
children from developing asthma and atopy10,11.  
The mean age of onset among the studied group 
was one year. This highlights the role of viral 
infections as inducers of wheezing in infancy. In the 
study of Hsu et al12 ,  30% of their patients had their 
onset of symptoms before the age of 14 years. 
Despite numerous studies on possible 
associations between environmental exposure and 
allergic disorders, any conclusions made remain a 
matter of controversy. Because almost all the 
studies were performed in Western countries, the 
application of these findings to people in other 
countries including Egypt may not be appropriate. 
In our series, factors precipitating acute 
exacerbations of bronchial asthma were viral upper 
respiratory tract infection, cold air, environmental 
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factors (such as tobacco smoke), fumes, food 
allergy, puberty, psychological stress, drugs, and 
menstruation in this order of frequency. Our data 
are close to those reported by Noble et al.13and 
Zhao et al.14 who reported that respiratory viral 
infections precipitated acute exacerbations of 
asthma and were the most common reason for 
hospital admissions. A study by El-Gamal et al.15 
revealed that 71% of asthmatic episodes in children 
were attributed to viral infections. 
The association of diet with respiratory 
symptoms and asthma in school children was 
studied in Taiwan by Tsai and Tsai16 who 
concluded that consumption of sweetened 
beverages and eggs were associated with increased 
risk of respiratory symptoms and asthma whereas 
consumption of soy products and fruits were 
associated with reduced risk of respiratory 
symptoms. In another study17, peanut and milk 
allergies were both associated with increased 
number of hospitalizations and milk allergy was 
associated with increased use of systemic steroids. 
On the other hand, Beausoeil et al18 concluded that 
asthma alone as a manifestation of food allergy was 
rare and avoidance of specific foods or additives 
had not been shown to improve asthma.  
Grass pollen had an increasing effect on asthma 
hospital admissions as reported by Erbas and 
coworkers19.  
El-Gamal and associates20 reported that 
cockroach sensitivity is quite prevalent in Cairo and 
it should be expected in moderate and severe 
bronchial asthma. The cockroach induced asthma in 
their study did not vary with the family history of 
allergy or the presence of other allergies in the 
individual. The latter observation suggests that 
cockroach allergy is mainly a respiratory one.  
Chilmonczyk and co-workers21 reported an 
association between exposure to environmental 
tobacco smoke and pulmonary morbidity in 
children with asthma. These data and ours 
emphasize the need for systemic, persistent efforts 
to stop the exposure of children with asthma to 
environmental tobacco smoke.  
Allergic diseases usually cluster in the same 
family, and this was evident in our series, also 
atopic family history was the most prominent risk 
factor for all types of allergic disorders in children 
in the study of Kalyoncu  et al8. 
In our study, dyspnea was the most frequent 
symptom of bronchial asthma exacerbation. This 
was in agreement with Roesner and Virchow22, who 
found that acute attacks of shortness of breath, dry 
cough and symptoms of concomitant 
rhinoconjunctivitis were the main clinical 
symptoms of asthma.  
Breast feeding in our limited series did not 
seem to confer protection against the development 
of bronchial asthma. Also  Mihrshahi et al23 stated 
that longer duration of breast feeding and later 
introduction of solid foods did not prevent the onset 
of asthma, eczema or atopy by age 5 years. On the 
other hand, the results of Kull and co-workers 24  
suggested that breast feeding during four months or 
more exhibited a reduced risk of asthma and 
wheezing.  
The Hb concentration varied from marked 
anemia to normal Hb. In a study by Shuttari25, Hb 
concentration was mildly reduced during asthma 
exacerbation. Other study reported changes in 
platelet behaviour and function during or after 
allergen exposure in patients suffering from asthma, 
allergic rhinitis and atopic dermatitis26. 
Serum total IgE level was high in 31.5% of our 
patients and normal in 12.79%. Another study 
found total serum IgE levels significantly higher for 
the children with asthma between ages 6 and 8 
years. Male gender was significantly associated 
with higher IgE levels when infants were 6 months 
of age in the same study 27.   
Inhaled corticosteroids remain the mainstay of 
treatment in persistent asthma as shown in our 
results. Similarly, Lipworth and Jackson28 stated 
that inhaled corticosteroids (ICSs) were first line 
drugs and most patients with mild to moderate 
asthma can be adequately controlled on low-to-
medium dosage of ICSs alone.  LABAs constitute 
an adjunctive therapy for patients not adequately 
controlled on low-medium dose ICSs29. The cost of 
LABAs and the concerns about side effects are the 
obstacles to its use on a wider scale in our 
community. 
Before reaching conclusions based on the 
present study, it is wise to consider a number of 
potential objections to the methodology. A first 
question will be : to what extent would further 
follow-up alter the estimate of the association 
between a postulated risk factor and bronchial 
asthma? Another potential source of bias is the 
small sample size of the followed up cases. 
In the current investigation, the only 
independent predictive risk factor for uncontrolled 
disease was the grade of bronchial asthma , and this 
is quite reasonable given the fact that persistent 
cases are less likely to remit. A longer follow up 
period would offer more reliable information. 
Perhaps the best study design to find out the natural 
course of asthma is a longitudinal prospective 
population-based cohort study. 
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In conclusion, these results pertain solely to our 
unit and should not be considered general; however, 
the methodology can be applied in relevant studies 
and in other centers.  
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